Search

Viatris Inc

Fechado

SetorSaúde

16.88 -0.24

Visão Geral

Variação de preço das ações

24h

Atual

Mín

16.86

Máximo

16.97

Indicadores-chave

By Trading Economics

Rendimento

-295M

-119M

Vendas

240M

3.8B

EPS

0.69

Rendimento de Dividendos

2.94

Margem de lucro

-3.162

Funcionários

30,000

EBITDA

9.4M

653M

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+14.93% upside

Dividendos

By Acuity

Rendimento de Dividendos

Médio do Setor

2.94%

2.18%

Próximos Ganhos

5 de nov. de 2026

Próxima data de dividendos

16 de set. de 2026

Próxima data de ex-dividendo

23 de nov. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-1.6B

19B

Abertura anterior

17.12

Fecho anterior

16.88

Sentimento de Notícias

By Acuity

50%

50%

131 / 339 Ranking em Healthcare

Viatris Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

4 de set. de 2026, 22:14 UTC

Viatris Inc is gaining in after-market trading, rising above its 20-day moving average and reaching a session high since Friday's close.

3 de set. de 2026, 19:56 UTC

Viatris Inc is trading lower, reflecting broader market trends. The stock reached a session low earlier, with no specific news identified for the movement.

2 de set. de 2026, 19:46 UTC

Viatris Inc. shares are trading higher during Wednesday's session, remaining above the 20-day moving average amid rising U.S. Treasury yields.

1 de set. de 2026, 20:09 UTC

Viatris Inc shares are higher, supported by strength in the Pharmaceuticals sub-sector. Earlier, the stock pulled back from a session high.

31 de ago. de 2026, 23:14 UTC

Shares of Viatris Inc. traded lower during after-market hours, reflecting broader market sentiment amid rising crude oil prices and geopolitical tensions.

28 de ago. de 2026, 19:51 UTC

Viatris Inc shares are trading lower today, breaking a trend of higher daily closes. No specific news has been identified to explain the decline.

27 de ago. de 2026, 23:02 UTC

Shares of Viatris Inc. traded lower in after-market hours. No specific company news was identified to explain the decline.

26 de ago. de 2026, 23:01 UTC

Shares of Viatris Inc declined in after-market trading, dropping from a peak to a low following four consecutive sessions of gains. No specific news was identified.

25 de ago. de 2026, 23:01 UTC

Viatris Inc shares are lower in after-market hours, reflecting a notable decline. The broader market initially showed strength but has since reversed some gains.

24 de ago. de 2026, 19:56 UTC

Viatris Inc shares are higher today, continuing a positive trend since Friday. Broader market conditions include a significant drop in crude oil prices.

21 de ago. de 2026, 23:01 UTC

Viatris Inc shares are lower in after-market hours, continuing a decline since Friday's close, with no specific news identified to explain the movement.

20 de ago. de 2026, 20:06 UTC

Viatris Inc shares are declining amid broader market trends, remaining below their 20-day moving average. Earlier in the session, shares briefly upticked before pulling back.

19 de ago. de 2026, 23:06 UTC

Viatris Inc. shares moved higher in after-market trading, despite remaining below the 20-day moving average and near the lower end of the one-month range.

18 de ago. de 2026, 23:01 UTC

Viatris Inc shares rose in after-market trading, recovering from session lows. This increase comes amid broader market concerns over rising U.S. Treasury yields.

17 de ago. de 2026, 23:16 UTC

Viatris Inc shares are trading higher in after-market hours, following earlier directional movement. No specific news was identified to explain the price action.

14 de ago. de 2026, 20:06 UTC

Viatris Inc shares are higher today, despite earlier session pullbacks. Broader market sentiment is mixed following a decline in U.S. retail sales.

13 de ago. de 2026, 20:06 UTC

Viatris Inc shares are lower today, reflecting broader market trends amid rising U.S. jobless claims that exceeded expectations. The stock remains near its one-month range low.

12 de ago. de 2026, 23:06 UTC

Viatris Inc. shares moved higher in after-market trading, recovering from earlier losses. The stock remains below its 20-day moving average.

11 de ago. de 2026, 23:41 UTC

Viatris Inc. shares rose in after-market trading, despite earlier fluctuations and broader market concerns about inflationary pressures and oil prices.

10 de ago. de 2026, 19:42 UTC

Pharmaceuticals sector strength is lifting Viatris Inc during Monday's session, with increased trading volume contributing to the upward movement.

7 de ago. de 2026, 22:01 UTC

Viatris Inc. shares are higher in after-market trading, supported by a broader equity rally following weaker employment data and reduced interest rate hike concerns.

6 de ago. de 2026, 23:01 UTC

Viatris Inc shares are higher in after-market hours, recovering from earlier lows. The stock is trading above Thursday's close despite recent declines.

5 de ago. de 2026, 23:11 UTC

Viatris Inc. shares are trading higher in after-market hours, recovering significantly above the 20-day moving average amid broader market optimism despite no specific news.

4 de ago. de 2026, 23:06 UTC

Viatris Inc shares are higher in after-market trading, reflecting positive momentum and positioning above the 20-day moving average. No specific news was identified.

3 de ago. de 2026, 20:06 UTC

Viatris Inc shares are higher today, reflecting broader market gains led by major stocks. The S&P 500 and Nasdaq 100 have also risen.

31 de jul. de 2026, 21:02 UTC

Viatris Inc shares are lower in after-market hours, continuing a four-session decline amid rising inflation concerns and higher crude oil prices.

30 de jul. de 2026, 18:56 UTC

Event

Viatris shares are trading lower despite FDA approval of the Gwyn Lo contraceptive patch. Broader economic data may be impacting the stock's performance.

29 de jul. de 2026, 22:03 UTC

Event

Viatris Inc. shares are lower in after-market hours despite FDA approval of the Gwyn Lo contraceptive patch, amid broader market caution over geopolitical tensions.

28 de jul. de 2026, 19:36 UTC

Social Media

Viatris shares are higher today, supported by strong sector gains and a significant rise in January 2027 $10 call options activity.

27 de jul. de 2026, 19:11 UTC

Viatris Inc shares are higher today, breaking a trend of daily gains. No specific news was identified to explain this movement.

Comparação entre Pares

Variação de preço

Viatris Inc Previsão

Preço-alvo

By TipRanks

14.93% parte superior

Previsão para 12 meses

Média 19.4 USD  14.93%

Máximo 23 USD

Mínimo 14 USD

Com base em 5 analistas de Wall Street que oferecem metas de preço de 12 meses para Viatris Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

5 ratings

2

Comprar

2

Manter

1

Vender

Sentimento

By Acuity

131 / 339 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Viatris Inc

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides it medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as glargine and SEMGLEE names. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; and Momenta Pharmaceuticals, Inc. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.
help-icon Live chat